Rchr
J-GLOBAL ID:201701008904765530   Update date: Sep. 29, 2020

Tanino Hirokazu

タニノ ヒロカズ | Tanino Hirokazu
Affiliation and department:
Job title: Professor
Homepage URL  (1): https://breastlife2020.com
Research field  (1): Tumor diagnostics and therapeutics
Research keywords  (6): TearExo ,  BRCAness ,  PDX ,  xenograft ,  exosome ,  Triple negative breast cancer
Papers (15):
  • Jun Yamamoto, Takuya Murata, Norihiko Sugisawa, Takashi Higuchi, Yoshihiko Tashiro, Hiroto Nishino, Sachiko Inubushi, Y U Sun, Hyein Lim, Kentaro Miyake, et al. Eribulin Regresses a Cisplatinum-resistant Rare-type Triple-negative Matrix-producing Breast Carcinoma Patient-derived Orthotopic Xenograft Mouse Model. Anticancer research. 2020. 40. 5. 2475-2479
  • Jun Yamamoto, Takuya Murata, Yoshihiko Tashiro, Takashi Higuchi, Norihiko Sugisawa, Hiroto Nishino, Sachiko Inubushi, Y U Sun, Hyein Lim, Kentaro Miyake, et al. A Triple-negative Matrix-producing Breast Carcinoma Patient-derived Orthotopic Xenograft (PDOX) Mouse Model Is Sensitive to Bevacizumab and Vinorelbine, Regressed by Eribulin and Resistant to Olaparib. Anticancer research. 2020. 40. 5. 2509-2514
  • Mitsuhiro Hayashi, Kyoko Nakazawa, Yoshie Hasegawa, Jun Horiguchi, Daishu Miura, Takashi Ishikawa, Shintaro Takao, Seung Jim Kim, Kazuhiko Yamagami, Masaru Miyashita, et al. Risk Analysis for Chemotherapy-induced Nausea and Vomiting (CINV) in Patients Receiving FEC100 Treatment. Anticancer research. 2019. 39. 8. 4305-4314
  • Robert M. Hoffman, Hirokazu Tanino. Clinical usefulness of the histoculture drug response assay for breast cancer. Methods in Molecular Biology. 2018. 1760. 93-100
  • Takashi Ishikawa, Kouhei Akazawa, Yoshie Hasegawa, Hirokazu Tanino, Jun Horiguchi, Daishu Miura, Mitsuhiro Hayashi, Norio Kohno. Survival outcomes of neoadjuvant chemotherapy with zoledronic acid for HER2-negative breast cancer. JOURNAL OF SURGICAL RESEARCH. 2017. 220. 46-51
more...
MISC (7):
  • Yoshimasa Kosaka, Naoko Minatani, Yoko Tanaka, Akiko Shida, Mariko Kikuchi, Hiroshi Nishimiya, Mina Waraya, Hiroshi Katoh, Takeo Sato, Norihiko Sengoku, et al. Lymph node metastasis and high serum CEA are important prognostic factors in hormone receptor positive and HER2 negative breast cancer. Molecular and clinical oncology. 2018. 9. 5. 566-574
  • Mariko Kikuchi, Mina Waraya, Naoko Minatani, Hiroshi Nishimiya, Hiroshi Katoh, Masayoshi Kosaka, Takumo Enomoto, Norihiko Senngoku, Hirokazu Tanino, Masahiko Watanabe. Examination about febrile neutropenia in patient performed FEC with breast cancer. ANNALS OF ONCOLOGY. 2015. 26. 142-143
  • Takafumi Sangai, Takashi Ishikawa, Norio Kohno, Daishu Miura, Eiichi Sato, Hiroshi Kaise, Masato Suzuki, Yoshie Hasegawa, Hirokazu Tanino, Jun Horiguchi, et al. Exploring biomarkers of response to zoledronic acid in breast cancer from clinical trial result of neoadjuvant chemotherapy with zoledronic acid: JONIE-1 study. CANCER RESEARCH. 2015. 75
  • Hirokazu Tanino, Yoshimasa Kosaka, Norihiko Sengoku, Mina Waraya, Hiroshi Nishimiya, Hirozhi Katoh, Mariko Kikuchi, Naoko Minatani, Saeko Teraoka, Takumo Enomoto, et al. BRCAness and prognosis in triple-negative breast cancer patients treated with neoadjuvant chemotherapy. CANCER RESEARCH. 2015. 75
  • Jun Yamamura, Norikazu Masuda, Daigo Yamamoto, Shigeru Tsuyuki, Masahide Yamaguchi, Satoru Tanaka, Junji Tsurutani, Sinya Tokunaga, Katsuhide Yoshidome, Makiko Mizutani, et al. THE COMBINATION CHEMOTHERAPY OF GEMCITABINE AND VINORELBINE IN HER2-NEGATIVE PATIENTS WITH TAXANE-PRETREATED METASTATIC BREAST CANCER: A PHASE II STUDY OF KINKI MULTIDISCIPLINARY BREAST ONCOLOGY GROUP (KMBOG) 1015 (UMIN000004839). BREAST. 2013. 22. S38-S38
more...
Lectures and oral presentations  (10):
  • Risk analysis for chemotherapy induced nausea and vomiting (CINV) in patients receiving FEC100 treatment
    (SAN ANTONIO BREAST CANCER SYMPOSIUM 43rd Annual SABCS 2018)
  • Phase 3 trial of carboplatin in triple negative breast cancer (TNBC) patients with residual invasive carcinoma after neoadjuvant chemotherapy (JONIE4:J-CAT trial)
    (SAN ANTONIO BREAST CANCER SYMPOSIUM 43rd Annual SABCS 2018)
  • BRCAness as a prognostic marker in triple-negative breast cancer patients treated with neoadjuvant chemotherapy: A multicenter retrospective study
    (SAN ANTONIO BREAST CANCER SYMPOSIUM 43rd Annual SABCS 2018)
  • オラパリブの乳癌適応拡大に向けた当院の取り組み
    (日本人類遺伝学会第63回大会 2018)
  • 乳癌切除標本における比誘電率計測と非侵襲マイクロ波散乱場断層イメージングに関する研究
    (第26回日本乳癌学会学術総会 2018)
more...
Education (1):
  • - 1987 Wakayama Medical University
Professional career (1):
  • 博士(医学) (和歌山県立医科大学)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page